Of het nu het mediterrane, paleo-, rauwkost- of dashdieet is, het kan allemaal. Diëten komen en gaan en sommige blijven bestaan. Een dieet is gewoonlijk een methode om gewicht te verliezen of om hypertensie, hypercholesterolemie of ontstekingen tegen te gaan. Daarentegen verdient het ketogeen dieet een ster in de medische wereld, omdat het bewezen effectief is bij de behandeling van refractaire epilepsie. Bovendien blijkt uit onderzoek dat het mogelijk helpt bij de behandeling van andere neurologische aandoeningen.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Figuren
Verschenen in
Referenties
Horst L van der. De ziekenhuisbehandeling van epilepsie. Ned Tijdschr Geneeskd1935;79:3126-31.
Rogovik AL, Goldman RD. Ketogenic diet for treatment of
epilepsy. Can Fam Phys 2010;56:540-2.
Freeman JM, Freeman JB, Kelly MT. The Ketogenic Diet: a
Treatment for Epilepsy. 3rd ed. New York, NY: Demos Health; 2000.
Seo JH, Lee YM, Lee JS et al. Efficacy and tolerability of the
ketogenic diet according to lipid:nonlipid ratios—comparison of 3:1
with 4:1 diet. Epilepsia 2007;48:801-5.
Liu YM, Wang HS. Medium-chain triglyceride ketogenic diet,
an effective treatment for drug-resistant epilepsy and a comparison
with other ketogenic diets. Biomed J 2013;36:9-15.
Hartman AL, Gasior M, Vining EPG et al. The neuropharmacology
of the ketogenic diet. Pediatr Neurol 2007;36:281-92.
Kim DY, Davis LM, Sullivan PG et al. Ketone bodies are
protective against oxidative stress in neocortical neurons.
Neurochem 2007;101:1316-26.
Paoli A, Rubini A, Volek JS et al. Beyond weight loss: a review
of the therapeutic uses of very-low-carbohydrate (ketogenic) diets.
Eur J Clin Nutr 2013;67:789-96.
Masino SA, Rho JM. Mechanisms of ketogenic diet action. In
Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta
AV, eds. Jasper’s Basic Mechanisms of the Epilepsies [Internet], 4th
ed. Bethesda, MD: National Center for Biotechnology Information;
2012. Available at https://www.ncbi.nlm.nih.gov/books/NBK98219/.
Accessed November 20, 2016.
Lund TM, Risa O, Sonnewald U et al. Availability of neurotransmitter
glutamate is diminished when beta-hydroxybutyrate replaces
glucose in cultured neurons. J Neurochem 2009;110:80-91.
Juge N, Gray JA, Omote H et al. Metabolic control of vesicular
glutamate transport and release. Neuron 2010;68:99-112.
Harvey J. Leptin regulation of neuronal excitability and cognitive
function. Curr Opin Pharmacol 2007;7:643-7.
Obeid M, Frank J, Medina M et al. Neuroprotective effects of
leptin following kainic acid-induced status epilepticus. Epilepsy
Behav 2010;19:278-83.
Egan B, D'Agostino DP. Fueling Performance: Ketones Enter the Mix. Cell Metab. 2016;24(3):373-375.
Cox PJ, Kirk T, Ashmore T, et al. Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes. Cell Metab. 2016.
Paoli A, Bianco A, Grimaldi KA. The Ketogenic Diet and Sport: A Possible Marriage? Exerc Sport Sci Rev. 2015;43(3):153-162.
Clarke K, Tchabanenko K, Pawlosky R, et al. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol. 2012;63(3):401-408.
Kesl SL, Poff AM, Ward NP, et al. Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague-Dawley rats. Nutr Metab (Lond). 2016;13:9.
Holdsworth D CP, Clarke K. Oral ketone body supplementation accelerates and enhances glycogen synthesis in human skeletal muscle following exhaustive exercise Proc Physiol Soc. 2016;35(PC12).
Lefevre F, Aronson N. Ketogenic diet for the treatment of
refractory epilepsy in children: a systematic review of efficacy.
Pediatrics 2000;105:E46.
Neal EG, Chaffe H, Schwartz RH et al. The ketogenic diet for
the treatment of childhood epilepsy: a randomized controlled trial.
Lancet Neurol 2008;7:500-6.
Neal EG, Chaffe H, Schwartz RH et al. A randomized trial of
classical and medium-chain triglyceride ketogenic diets in the
treatment of childhood epilepsy. Epilepsia 2009;50:1109-17.
Gasior M, Rogawski MA, Hartman AL. Neuroprotective and
disease-modifying effects of the ketogenic diet. Behav Pharmacol
2006;17:431-9.
Henderson ST. High carbohydrate diets and Alzheimer’s disease.
Med Hypotheses 2004;62:689-700.
Van der Auwera I, Wera S, Van Leuven F et al. A ketogenic
diet reduces amyloid beta 40 and 42 in a mouse model of
Alzheimer’s disease. Nutr Metab (Lond) 2005;2:28. Published
online 2005 Oct 17.
Kashiwaya, Y.; Takeshima, T.; Mori, N.; Nakashima, K.; Clarke, K.; Veech, R.L. D-beta-hydroxybutyrate
protects neurons in models of Alzheimer’s and Parkinson’s disease. Proc. Natl. Acad. Sci. USA 2000, 97,
5440–5444. [CrossRef]
Mohorko N, Černelič-Bizjak M, Poklar-Vatovec T, Grom G, Kenig S, Petelin A,
Jenko-Pražnikar Z. Weight loss, improved physical performance, cognitive
function, eating behavior, and metabolic profile in a 12-week ketogenic diet in
obese adults. Nutr Res. 2019 Feb;62:64-77. doi: 10.1016/j.nutres.2018.11.007.
Epub 2018 Nov 12. PubMed PMID: 30803508.
Govers E, Otten A, Schuiling B, Bouwman W, Lourens A, et al. (2019) Effectiveness of a Very Low Carbohydrate Ketogenic Diet
Compared to a Low Carbohydrate and Energy-Restricted Diet in Overweight/Obese Type 2 Diabetes Patients. Int J Endocrinol Metab Disord
5(2): dx.doi.org/10.16966/2380-548X.158
Walton CM, Perry K, Hart RH, Berry SL, Bikman BT. Improvement in Glycemic and
Lipid Profiles in Type 2 Diabetics with a 90-Day Ketogenic Diet. J Diabetes Res.
2019 Aug 14;2019:8681959. doi: 10.1155/2019/8681959. eCollection 2019. PubMed
PMID: 31485454; PubMed Central PMCID: PMC6710763.
McDonald TJW, Cervenka MC. Lessons learned from recent clinical trials of
ketogenic diet therapies in adults. Curr Opin Clin Nutr Metab Care. 2019 Sep 9.
doi: 10.1097/MCO.0000000000000596. [Epub ahead of print] PubMed PMID: 31503023.
